PTHrP analogue
Abaloparatide clinical trials
Answer
Abaloparatide has 25 registered trials: 7 running, 14 completed, 3 stopped early. 11 posted results.
Trial registerClinicalTrials.gov, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT03841058 Trial register | Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery | running, but no longer enrolling | - | 2019-02-15 | - |
| NCT07587775 Trial register | The Effect of Osteoporotic Medications on Vertebral Bone Quality Score | enrolling by invitation only | - | 2026-05-14 | - |
| NCT06164795 Trial register | Sequential Therapies After Osteoanabolic Treatment | currently recruiting participants | - | 2023-12-11 | - |
| NCT04467983 Trial register | Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone | running, but no longer enrolling | - | 2020-07-13 | - |
| NCT04167163 Trial register | Abaloparatide Before Total Knee Arthroplasty | completed | - | 2019-11-18 | Posted |
| NCT07616401 Trial register | MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis | currently recruiting participants | - | 2026-06-01 | - |
| NCT06898060 Trial register | To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture | not yet recruiting participants | - | 2025-03-27 | - |
| NCT06753864 Trial register | A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the R | not yet recruiting participants | - | 2024-12-23 | - |
| NCT04760782 Trial register | PTH Analog Type II Odontoid Fracture | terminated before completion | - | 2021-02-18 | Posted |
| NCT04249232 Trial register | Abaloparatide and Pelvic Fracture Healing | completed | - | 2020-01-30 | - |
| NCT04626141 Trial register | Supracondylar Distal Femur Fractures and Abaloparatide | withdrawn before enrolling anyone | - | 2020-11-12 | - |
| NCT04974723 Trial register | Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women | completed | - | 2021-07-23 | Posted |
| NCT06154187 Trial register | Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis | last verified some time ago; the register no longer confirms its status | - | 2023-11-20 | - |
| NCT04366726 Trial register | Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopa | completed | - | 2020-04-29 | Posted |
| NCT03512262 Trial register | Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) | completed | - | 2018-04-30 | Posted |
| NCT04064411 Trial register | Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis | completed | - | 2019-08-21 | Posted |
| NCT03746041 Trial register | A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes | completed | - | 2018-11-19 | - |
| NCT04663464 Trial register | Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women. | completed | - | 2020-12-11 | - |
| NCT04936984 Trial register | Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women. | completed | - | 2021-06-23 | - |
| NCT03710889 Trial register | Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption | completed | - | 2018-10-18 | Posted |
| NCT03708926 Trial register | Effect of Abaloparatide on Lumbar Disc Degeneration | withdrawn before enrolling anyone | - | 2018-10-17 | - |
| NCT01657162 Trial register | Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis | completed | - | 2012-08-06 | Posted |
| NCT01674621 Trial register | Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis | completed | - | 2012-08-29 | Posted |
| NCT00542425 Trial register | Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis | completed | - | 2007-10-11 | Posted |
| NCT01343004 Trial register | Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women | completed | - | 2011-04-27 | Posted |
Source: ClinicalTrials.gov, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.